.png?width=500&height=250&name=Untitled%20design%20(100).png)
When Billing Outruns Care: What the Proposed RPM Rule Change Teaches Independent Pharmacies About LTC@H
When Billing Outruns Care: What the Proposed RPM Rule Change Teaches Independent Pharmacies About LTC@H
A look at a regulatory shift in remote monitoring, and why the operations behind a service matter as much as the enrollment paperwork
If you have never heard of remote physiologic monitoring (RPM), you are in good company. It is a Medicare-billed service category that drew a lot of regulatory attention in 2026. It is worth understanding because of what it shows about how regulators respond when billing grows faster than the care behind it.
What RPM and RTM are
Remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) let practices bill Medicare for tracking a patient's health data between visits, such as blood pressure or glucose readings. When it works well, a clinician sees a concerning trend early and can act before a small problem becomes a hospital stay.
What CMS proposed, and why
In July 2026, the Centers for Medicare & Medicaid Services (CMS) proposed changes to RPM and RTM in the Medicare Physician Fee Schedule. Under the proposal, beginning January 1, 2027, payment would be allowed only when services are furnished by clinical staff who are directly employed by, or under the direct supervision of, the billing practitioner. That would effectively bar third-party vendors from the model.
CMS's stated concern is fraud, waste and abuse. It points to arrangements where beneficiaries are solicited for monitoring, they do not need, or where services are billed without meaningful clinical oversight.
The congressional pushback
Thirty-two bipartisan members of the House of Representatives, led by Reps. David Kustoff (R-TN) and Troy Balderson (R-OH), wrote to CMS Administrator Dr. Mehmet Oz asking CMS to roll back the restriction. They argue it would cut access for rural patients and small independent practices. Fierce Healthcare reported in the letter in "Lawmakers press CMS to roll back proposed restrictions on remote patient monitoring."
The final rule is expected around November 2026. It has not been issued, so the outcome is pending.
The lesson: categories get judged by their weakest links
Whatever the final rule says, the pattern is useful to recognize. When billing in a service category outruns real care delivery, regulators often respond to the whole category, not only the bad actors. Legitimate providers then absorb the consequences. In RPM, even well-run programs are now facing proposed restrictions.
For any pharmacy service line that reimburses well, the takeaway is the same: the strength of the operations behind the claims is what protects the category, and the pharmacies in it.
How this maps to LTC@H
A pharmacy can obtain an LTC NPI, finish payer enrollment paperwork and begin billing without the operational infrastructure behind it. The typical startup items are modest: an LTC PSAO, an after-hours call service (about $50 per month), backup pharmacy and IV compounding access (about $50 per month), the LTC NPI ($400, one-time) and an ESI application ($500, one-time).
Completing those steps gets a pharmacy into LTC@H. It does not mean the pharmacy is running a real LTC@H program. The difference is the daily service delivered to patients, and that is what payers such as ESI, Optum, Navitas, Lexior and Prime Therapeutics ultimately care about, because payers are the ones who audit. Home-based pharmacy care, delivered well, supports better medication adherence and fewer avoidable hospital stays. That only holds when the care happens.
What a real LTC@H program requires, and why
After-hours coverage. Patients and caregivers do not have medication questions only between 9 and 5. An after-hours call service shows that someone clinically capable is reachable when a facility or family needs help. A reviewer would expect to see that the coverage exists, is staffed, and is used.
Compliance packaging and vial conversion. Packaging that organizes doses by day and time supports adherence, which is the clinical reason the service exists. Many patients start on vials, so converting them is real work, not a formality. A payer looking at a claim for an LTC@H patient would reasonably ask whether that patient is actually receiving the service.
Delivery logistics. Reliable, documented delivery, whether in-house or contracted, is how the medication reaches the patient on schedule. Gaps in delivery are gaps in care, and records of when and where medications went are what a reviewer would look for.
Sterile compounding and IV access. Not every pharmacy provides these services itself. A backup pharmacy arrangement means a patient who needs them is not left without. Having the arrangement in place before it is needed is the point.
Identifying qualifying patients properly. A population assessment based on 90 days of claims data helps a pharmacy find patients who actually qualify, rather than relying on assumptions. A defensible, documented method for who is enrolled and why is exactly what an auditor will ask about, and it echoes CMS's concern about services provided to people who do not need them.
Consistently following new processes. Following new workflows reliably is one of the most common challenges in the first six months. A process followed on some days and skipped on others produces uneven records and uneven care.
Your own quality assurance. Each pharmacy manages its own quality assurance and performance monitoring. Checking your own work regularly is how problems get caught internally before an outside reviewer finds them.
A readiness checklist
If you cannot check a box, that is simply your next project.
- After-hours call service is active and staffed.
- Compliance packaging equipment, workflow and staff time are in place.
- There is a plan to convert existing vial patients, not only new ones.
- Delivery is reliable and documented.
- A backup arrangement covers sterile compounding and IV services.
- Patients are identified through a structured claims-based assessment.
- Staff follow new processes consistently, and you can show it.
- You have your own method for monitoring quality and performance.
A note from the author
LTC@Home Pharmacy Network is one resource available to independent pharmacies exploring or already providing LTC@H services. Each pharmacy remains responsible for its own compliance and billing. If you have questions about any of the above, you are welcome to reach out.
This article is for educational purposes only and is not legal, billing or compliance advice. The RPM and RTM proposal discussed here is not final. Please consult your own counsel or compliance advisor about your pharmacy's specific obligations.